The cost of measles in industrialised countries

H. Carabin, William Edmunds, M. Gyldmark, P. Beutels, D. Lévy-Bruhl, H. Salo, U. K. Griffiths

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

The aim of this study is to estimate the costs of measles and measles control in 11 industrialised countries with varying levels of measles vaccine coverage. Country-specific annual incidence of measles, measles immunization policy, coverage and costs data were collected. The average societal costs of measles cases and immunisation programme per capita were calculated. These 11 countries spend together over US$ 151 million every year to treat and control measles. Per capita costs of measles control tend to be higher in countries with poorer measles control programmes (for instance, Italy has the highest incidence and highest overall costs), though many other factors, such as the number of antigens given per clinic visit and the local price of MMR also affect the efficiency of the programme. The costs estimates presented here can be used to estimate potential savings that might accrue from changes to measles control programmes.

Original languageEnglish
Pages (from-to)4167-4177
Number of pages11
JournalVaccine
Volume21
Issue number27-30
DOIs
Publication statusPublished - 1 Oct 2003

Keywords

  • Cost analysis
  • Industrialised countries
  • Measles

Fingerprint

Dive into the research topics of 'The cost of measles in industrialised countries'. Together they form a unique fingerprint.

Cite this